Skip to content

DR. JANKIE SASKIA

Active
Private limited companyfounded 2002active for 24 yearsHerentalsebaan 33, 2390 Malle, BelgiumKBO/BCE: BE 0476.909.111

From the official registers: KBO 24 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR. JANKIE SASKIA has been active since 2002 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €571,110 and a net result of €42,713. Equity has been growing by about 15% per year since 2018. Its solvency ranks better than 72% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 18-02-2002 Normal situation
Activity
Specialist medical practice NACE 86220and 1 other
Establishment unit
2.229.191.345 2390 Malle, since 14-02-2002
Financial year end
31 December
Peppol
Reachable since 16-09-2025

Board and ownership

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€100,338
▼ 42.7%
Turnover
≈ €190,000
estimated
Profit
€42,713
▼ 41.9%
Equity
€571,110
▲ 8.1%
Total assets
€699,699
▼ 0.4%
Filed on 13-07-2026, 18 days before the deadlineat the National Bank
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 18.95, cash €391,285Equity €571,110 (81.6% of total assets)Size: total assets €699,699Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 62% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 81.6% of total assets
Liquidity 100=
short-term debt 3.2% · cash 55.9%
Profitability 76-6
return on assets 6.1%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €50,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 18.95 (7.83 in 2024), above the usual 1.5. Short-term debt is 3.2% and cash 55.9% of total assets. 18.4% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 21% on profitability and 50% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 18.95, cash €391,285
NBB · annual accounts
lowers risk · Equity €571,110 (81.6% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €699,699
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
18 days early
2024
17 days early
2023
21 days early
2022
5 days early
2021
11 days early
2020
11 days early
2019
73 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 1 day before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 14 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 8th oldest company in Malle, Health and social work sectorin the Checked rankings No. 8 View
  • Positive: 8 profitable years in a rowprofit 2025: €42,713 8 years View
  • Positive: Filed on time since financial year 2020accounts within the deadline every year 6 years View

Comparable companies

These companies have the same main activity as DR. JANKIE SASKIA: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €619,000 and €816,000, founded between 2000 and 2002.

CompanyTotal assetsGross margin
DR. JANKIE SASKIA Malle€699,699€100,338
DOKTER ERWIN SCHROYENS Mechelen€633,692€91,211
DOKTER LYSSENS & VERCRUYSSE Lier€815,620€98,338
DERMATO - BAILLE Lens (Hainaut)€717,714€101,698
CABINET DR. EL FOULY P.E. Waterloo€767,451€98,613
DOKTER RITA VAN GINDERDEUREN Diest€647,724€93,678
CABINET MEDICAL DU DOCTEUR WALRAVENS Thuin€618,577€98,739
Full comparison

Documents

Annual accounts at the NBB

All 24 annual accounts

Articles and registers

Key facts about DR. JANKIE SASKIA

What is the company number of DR. JANKIE SASKIA?
The company number of DR. JANKIE SASKIA is 0476.909.111. The VAT number is the same number with BE in front: BE 0476.909.111.
Where is DR. JANKIE SASKIA based?
The registered office is at Herentalsebaan 33, 2390 Malle.Company details
What does DR. JANKIE SASKIA do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. JANKIE SASKIA?
The legal form of DR. JANKIE SASKIA is Private limited company (BV).
When was DR. JANKIE SASKIA founded?
DR. JANKIE SASKIA was founded on 18-02-2002.
Is DR. JANKIE SASKIA still active?
Yes, DR. JANKIE SASKIA is an active enterprise in the KBO register.
How many employees does DR. JANKIE SASKIA have?
DR. JANKIE SASKIA had an average of 1 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
What is the turnover of DR. JANKIE SASKIA?
The turnover in financial year 2025 is ≈ €190,000. This figure is estimated from the gross margin of €100,338 and 43 comparable companies (NACE 86220). It probably lies between €160,000 and €250,000.
Is DR. JANKIE SASKIA profitable?
In financial year 2025, DR. JANKIE SASKIA made a profit of €42,713.
Where can I find the annual accounts of DR. JANKIE SASKIA?
DR. JANKIE SASKIA filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of DR. JANKIE SASKIA due?
DR. JANKIE SASKIA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.